256 related articles for article (PubMed ID: 33849428)
1. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
[TBL] [Abstract][Full Text] [Related]
2. Association study of SNPs in LncRNA CDKN2B-AS1 with breast cancer susceptibility in Chinese Han population.
Sun Q; Chong F; Jiang X; Wang Y; Xu K; Zou Y; Song C
Int J Biochem Cell Biol; 2022 Feb; 143():106139. PubMed ID: 34954153
[TBL] [Abstract][Full Text] [Related]
3. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (
Yuan W; Zhang W; Zhang W; Ruan ZB; Zhu L; Liu Y; Mi YY; Zhang LF
Bioengineered; 2020 Dec; 11(1):1084-1098. PubMed ID: 33054494
[TBL] [Abstract][Full Text] [Related]
4. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
5. [The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients].
Xu Y; Shao XX; Hu DY; Rao SY; Xiao HY; Fang Y; Jiang Y
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(32):2513-2522. PubMed ID: 36008322
[No Abstract] [Full Text] [Related]
6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
10. Migration/Differentiation-Associated LncRNA
Al Ageeli E; Attallah SM; Mohamed MH; Almars AI; Kattan SW; Toraih EA; Fawzy MS; Darwish MK
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360233
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
15. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
17. CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients from the United States.
Pasquale LR; Loomis SJ; Kang JH; Yaspan BL; Abdrabou W; Budenz DL; Chen TC; Delbono E; Friedman DS; Gaasterland D; Gaasterland T; Grosskreutz CL; Lee RK; Lichter PR; Liu Y; McCarty CA; Moroi SE; Olson LM; Realini T; Rhee DJ; Schuman JS; Singh K; Vollrath D; Wollstein G; Zack DJ; Allingham RR; Pericak-Vance MA; Weinreb RN; Zhang K; Hauser MA; Richards JE; Haines JL; Wiggs JL
Am J Ophthalmol; 2013 Feb; 155(2):342-353.e5. PubMed ID: 23111177
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients.
Bayoglu B; Yuksel H; Cakmak HA; Dirican A; Cengiz M
Clin Biochem; 2016 Jul; 49(10-11):821-7. PubMed ID: 26944720
[TBL] [Abstract][Full Text] [Related]
19. Effects of CDKN2B-AS1 polymorphisms on the susceptibility to coronary heart disease.
Huang K; Zhong J; Li Q; Zhang W; Chen Z; Zhou Y; Wu M; Zhong Z; Lu S; Zhang S
Mol Genet Genomic Med; 2019 Nov; 7(11):e955. PubMed ID: 31496134
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CDKN2B-AS1 enhances LPS-induced apoptotic and inflammatory damages in human lung epithelial cells via regulating the miR-140-5p/TGFBR2/Smad3 signal network.
Wang B; Sun Q; Ye W; Li L; Jin P
BMC Pulm Med; 2021 Jun; 21(1):200. PubMed ID: 34126975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
